Study Country Case (T/C, Age (T/C, y) Sex (M/F) Intervention Baseline CVP (T/C) Surgery Diagnosis T C
Otsubo et al. 2004 [13 ] Japan 47/56 59.3 ± 14.4/55.4 ± 16.1 30/17 41/15 IVCC/control 10.6 ± 2.6/10.1 ± 2.8 Hepatectomy Hepatocarcinoma (28/31), metastatic tumor (10/14), cholangiocellular carcinoma (5/4), others (4/7) Chen et al. 2006 [14 ] China 60/58 39.7 ± 3.6/41.5 ± 4.1 53/7 51/7 IVCC/control 7.6 ± 3.0/7.7 ± 2.4 Hepatectomy HBV related cirrhosis (51/54), HCV related cirrhosis (6/4), others (1/2) Wang et al. 2006 [15 ] China 25/25 45.3 ± 14.6/46.0 ± 12.1 19/6 21/4 IAC/control — Hepatectomy Liver cirrhosis (14/15), others (11/10) Kato et al. 2008 [16 ] Japan 43/42 65 (28–82)/67 (38–79) — — IVCC/control 7 (3–14)/7 (2–16) Liver resection Hepatocarcinoma (35/34), metastatic tumor (6/7), cholangiocellular (1/0) Liu et al. 2008 [17 ] China 23/23 45.4 ± 13.0/42.9 ± 12.6 14/9 16/7 IAC/control 2.7–5.4 Liver resection Hepatocarcinoma (23/23) Uchiyama et al. 2009 [18 ] Japan 20/58 61.6 ± 12.9/64.8 ± 16.8 15/5 44/14 IVCC/control — Hepatectomy Hepatocarcinoma (9/31), metastatic tumor (6/20), others (5/7) Feng et al. 2010 [19 ] China 43/43 48 ± 10/47 ± 12 6/37 8/35 IAC/control 10 (6–12)/10 (6–11) Transplantation Hepatocirrhosis (15/16), severe hepatitis (7/8), carcinoma (19/17), others (2/2) Liu et al. 2010 [20 ] China 67/83 51 (33–69)/55 (14–76) 48/35 55/12 IVCC/control 7.8 ± 3.5/8.3 ± 3.6 Liver lobectomy Primary liver carcinoma (67/83) Rahbari et al. 2011 [21 ] Germany 65/63 57.2 ± 10.9/59.2 ± 12.1 37/28 42/21 IVCC/IAC 9.2 ± 3.6/7.6 ± 3.6 Liver resection Hepatocarcinoma (19/20), metastatic tumor (35/37), others (11/6) Zhu et al. 2012 [22 ] China 96/96 — — — IVCC/IAC 10.5 ± 1.3/10.8 ± 1.2 Liver resection Liver tumors (96/96) Yang et al. 2013 [23 ] China 60/53 48.7 ± 10.8/49.5 ± 12.1 43/17 38/15 IVCC/control 7.6 ± 3.2/— Hepatectomy Hepatocarcinoma (31/26), metastatic tumor (7/7), others (22/20) Ryu et al. 2010 [24 ] South Korea 19/19 29 ± 11/26 ± 9 15/3 18/1 IAC/control 8.5/7.5 Liver lobectomy Donors (19/19) Wang et al. 2013 [25 ] China 33/32 37.1 ± 10.1/35.9 ± 10.3 26/7 26/6 IAC/control — Liver lobectomy Hepatocarcinoma (11/18), hepatocirrhosis (16/12), hepatitis B (4/1), others (2/1)
